Gritstone Bio Inc (GRTS)
0.9627
+0.09
(+10.66%)
USD |
NASDAQ |
May 03, 16:00
0.9633
0.00 (0.00%)
After-Hours: 20:00
Gritstone Bio Free Cash Flow: -126.22M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -126.22M |
| September 30, 2023 | -138.38M |
| June 30, 2023 | -133.11M |
| March 31, 2023 | -128.21M |
| December 31, 2022 | -121.82M |
| September 30, 2022 | -115.07M |
| June 30, 2022 | -104.51M |
| March 31, 2022 | -101.07M |
| December 31, 2021 | -56.14M |
| September 30, 2021 | -56.52M |
| June 30, 2021 | -60.97M |
| Date | Value |
|---|---|
| March 31, 2021 | -58.37M |
| December 31, 2020 | -92.62M |
| September 30, 2020 | -95.18M |
| June 30, 2020 | -105.15M |
| March 31, 2020 | -104.06M |
| December 31, 2019 | -101.18M |
| September 30, 2019 | -88.42M |
| June 30, 2019 | -56.27M |
| March 31, 2019 | -48.78M |
| December 31, 2018 | -43.82M |
Free Cash Flow Range, Past 5 Years
-138.38M
Minimum
Sep 2023
-56.14M
Maximum
Dec 2021
-97.01M
Average
-101.18M
Median
Dec 2019
Free Cash Flow Benchmarks
| Precision BioSciences Inc | -86.39M |
| Humacyte Inc | -75.58M |
| Verastem Inc | -86.46M |
| BioVie Inc | -41.11M |
| Adial Pharmaceuticals Inc | -6.807M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.51M |
| Cash from Investing (Quarterly) | 38.30M |
| Cash from Financing (Quarterly) | 15.72M |
| Free Cash Flow Per Share (Quarterly) | -0.1678 |
| Free Cash Flow to Equity (Quarterly) | -29.98M |
| Free Cash Flow Yield | -113.5% |